Biotech

All Articles

Former Seagen CEO unveils brand new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2015 for a whopping $43 bil...

Ironwood makes more purpose $1B GI medication along with brand new subgroup information

.On the heels of a phase 3 gain that stopped working to thrill clients, Ironwood Pharmaceuticals is ...

Novartis inks $150M deal for autoimmune molecular adhesive

.Don't stop Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball af...

Jade carves out exec crew along with Chinook vets-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings a...

Septerna goes public along with upsized offering of $288M

.Celebrating his firm's upsized going public (IPO), Septerna chief executive officer Jeffrey Finer c...

AbbVie creates Richter wealthier, paying out $25M to form finding pact

.AbbVie has gone back to the source of its own antipsychotic powerhouse Vraylar searching for yet an...

GenSight enters into ultimate full weeks of money path as income stream noses out of scope

.GenSight Biologics is actually weeks off of running out of loan. Once more. The biotech merely poss...

AZ licenses discarded uncommon disease medicine to Monopar Therapies

.Monopar Rehabs is actually recuperating a medication from the dump of AstraZeneca's unusual health ...

Arcus' brand-new HIF-2a data in kidney cancer cells mention possible edge over Merck's Welireg, professionals say

.With brand new records out on Arcus Biosciences' speculative HIF-2a prevention, one group of analys...

Roche wagers as much as $1B to grow Dyno gene treatment delivery deal

.After creating a genetics treatment alliance with Dyno Rehabs in 2020, Roche is actually back for e...